SCHEMBL3873162

SCHEMBL3873162

CN1CCc2c([nH]c3cc([N+](=O)[O-])ccc23)C1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.57
MEN1 O00255 3/20 0.50
KMT2A Q03164 3/20 0.50
MAPT P10636 2/20 0.50
GFER P55789 1/20 0.50
SMN1; SMN2 Q16637 1/20 0.50
BAZ2B Q9UIF8 1/20 0.49
TRPV1 Q8NER1 3/20 0.48
FAAH O00519 1/20 0.48
PARP1 P09874 1/20 0.45
GRIA1 P42261 3/20 0.44
GRIA2 P42262 3/20 0.44
GRIA3 P42263 3/20 0.44
GRIA4 P48058 3/20 0.44
SLC6A4 P31645 1/20 0.44
CHRNA7 P36544 1/20 0.44
DRD2 P14416 2/20 0.43
DRD1 P21728 2/20 0.43
DRD4 P21917 2/20 0.43
DRD5 P21918 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3877880 0.90 MAPT (0.64) KDM4EMEN1KMT2AMAPTGFER
SCHEMBL21904126 0.81 TRPV1 (0.59) MEN1KMT2AMAPTGFERSMN1; SMN2
SCHEMBL13328971 0.80 BAZ2B (0.71) KDM4EMEN1KMT2AMAPTGFER
SCHEMBL28367793 0.79 TRPV1 (0.58) MEN1KMT2AMAPTGFERSMN1; SMN2
SCHEMBL16140437 0.78 MAPT (0.78) KDM4EMEN1KMT2AMAPTGFER
SCHEMBL18034956 0.78 KDM4E (0.66) KDM4EMEN1KMT2ATRPV1CHRNA7
SCHEMBL3881136 0.77 KDM4E (0.64) KDM4EMEN1KMT2ABAZ2BCHRNA7
SCHEMBL16624341 0.77 KDM4E (0.64) KDM4EMEN1KMT2ABAZ2BTRPV1
SCHEMBL20910234 0.77 KDM4E (0.64) KDM4EMEN1KMT2ACHRNA7DRD2
SCHEMBL1120432 0.77 KDM4E (0.64) KDM4EMEN1KMT2ASMN1; SMN2BAZ2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8263609-B2 Tetrahydro-β-carbolin-sulfonamide derivatives as 5-Ht6 ligands LABORATORIOS DEL DR. ESTEVE, S.A. (ES) 2012-09-11 US disclosed
EP-1919475-B1 TETRAHYDRO- BETA-CARBOLIN-SULFONAMIDE DERIVATIVES AS 5-HT6 LIGANDS ESTEVE LABOR DR (ES) 2009-03-11 EP disclosed
US-20080280942-A1 Tetrahydro-Beta-Carbolin-Sulfonamide Derivatives as 5-Ht6 Ligands LABORATORIES DEL DR. ESTEVE, S.A. (ES) 2008-11-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080280942-A1 Tetrahydro-Beta-Carbolin-Sulfonamide Derivatives as 5-Ht6 Ligands HTR6, HTR5A, HTR1B KDM4E 4813/4885MEN1 2781/4885KMT2A 3664/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.